Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells

Contribution of Epithelial Plasticity to Therapy Resistance

(2019) Patricia G. Santamaría et al.   Journal of Clinical Medicine

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

(2018) François-Clément Bidard et al.   JNCI-Journal of the National Cancer Institute

AR Expression in Breast Cancer CTCs Associates with Bone Metastases

(2018) Nicola Aceto et al.   MOLECULAR CANCER RESEARCH

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

(2018) François-Clément Bidard et al.   JNCI-Journal of the National Cancer Institute

Identification of the tumour transition states occurring during EMT

(2018) Ievgenia Pastushenko et al.   NATURE

AR-Variant–Positive CTC: A Surrogate for a Surrogate for Taxane Therapy Outcome?

(2018) Scott M. Dehm et al.   CLINICAL CANCER RESEARCH

CTCs‐derived xenograft development in a triple negative breast cancer case

(2018) Tais Pereira‐Veiga et al.   INTERNATIONAL JOURNAL OF CANCER

A magic drug target: Androgen receptor

(2018) Dan Li et al.   MEDICINAL RESEARCH REVIEWS

Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer

(2018) Maria A Papadaki et al.   MOLECULAR CANCER THERAPEUTICS

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

(2018) Massimo Cristofanilli et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide

(2017) Emmanuel S. Antonarakis et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of Circulating Tumor Cell (CTC) Monitoring in Evaluating Prognosis of Triple-Negative Breast Cancer Patients in China

(2017) Yanwu Zhang et al.   MEDICAL SCIENCE MONITOR

Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort

(2016) Sara Jansson et al.   BMC CANCER

EMT: 2016

(2016) M. Angela Nieto et al.   CELL

Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer

(2016) Guangcun Cheng et al.   Molecular Cancer

Metastatic colonization by circulating tumour cells

(2016) Joan Massagué et al.   NATURE

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

(2016) Giampaolo Bianchini et al.   Nature Reviews Clinical Oncology

The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis

(2016) Yan-jun Lu et al.   Oncotarget

Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients

(2016) Sofia Agelaki et al.   Oncotarget

Tackling Cancer Stem Cells via Inhibition of EMT Transcription Factors

(2016) Megan Mladinich et al.   Stem Cells International

Anti-androgen therapy in triple-negative breast cancer

(2016) Valerie N. Barton et al.   Therapeutic Advances in Medical Oncology

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2015) E. Senkus et al.   ANNALS OF ONCOLOGY

EMT, CTCs and CSCs in tumor relapse and drug-resistance

(2015) Abhisek Mitra et al.   Oncotarget

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

(2014) Lorena Alonso-Alconada et al.   Molecular Cancer

Epithelial-to-Mesenchymal Transition and Autophagy Induction in Breast Carcinoma Promote Escape from T-cell-Mediated Lysis

(2013) I. Akalay et al.   CANCER RESEARCH

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

(2013) H. Masuda et al.   CLINICAL CANCER RESEARCH

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

(2013) Irène Baccelli et al.   NATURE BIOTECHNOLOGY

Circulating Tumor Cells: Application as a Biomarker for Molecular Characterization and Predictor of Survival in an All-Comer Solid Tumor Phase I Clinical Study

(2013) Haifeng Bao et al.   PLoS One

Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

(2013) M. Yu et al.   SCIENCE

Expression of androgen receptors in triple negative breast carcinomas

(2012) Ivana Mrklić et al.   ACTA HISTOCHEMICA

A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer

(2012) Jorge Barbazán et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Plasma Markers for Identifying Patients with Metastatic Melanoma

(2011) H. M. Kluger et al.   CLINICAL CANCER RESEARCH

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study

(2011) Laura C Collins et al.   MODERN PATHOLOGY

Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients

(2010) William K. Oh et al.   CANCER

Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients

(2009) M Mego et al.   BRITISH JOURNAL OF CANCER

Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival

(2009) Charlotte Aaberg-Jessen et al.   JOURNAL OF NEURO-ONCOLOGY

Progress in matrix metalloproteinase research

(2008) G MURPHY et al.   MOLECULAR ASPECTS OF MEDICINE

Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities

(2008) W. G. Stetler-Stevenson   Science Signaling